Literature DB >> 27778640

Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study.

Richard S Legro1,2, Allen R Kunselman2, Christy M Stetter2, Carol L Gnatuk1, Stephanie J Estes1, Eleanor Brindle3, Hubert W Vesper3, Julianne C Botelho4, Peter A Lee5, William C Dodson1.   

Abstract

Context: Daughters of women with polycystic ovary syndrome (PCOS) are thought to be at increased risk for developing stigmata of the syndrome, but the ontogeny during puberty is uncertain. Objective: We phenotyped daughters (n = 76) of mothers with PCOS and daughters (n = 80) from control mothers for reproductive and metabolic parameters characteristic of PCOS. Design, Setting, and Participants: We performed a matched case/control study at Penn State Hershey Medical Center that included non-Hispanic, white girls 4 to 17 years old. Intervention: We obtained birth history, biometric, ovarian ultrasounds, whole-body dual-energy X-ray absorptiometry scan for body composition, 2-hour glucose challenged salivary insulin levels, and two timed urinary collections (12 hours overnight and 3 hours in the morning) for gonadotropins and sex steroids. Main Outcome Measures: We measured integrated urinary levels of adrenal (dehydroepiandrosterone sulfate) and ovarian [testosterone (TT)] steroids. Other endpoints included integrated salivary insulin levels and urinary luteinizing hormone levels.
Results: There were no differences in detection rates or mean levels for gonadotropins and sex steroids in timed urinary collections between PCOS daughters and control daughters, nor were there differences in integrated salivary insulin levels. Results showed that 69% of Tanner 4/5 PCOS daughters vs 31% of control daughters had hirsutism defined as a Ferriman-Gallwey score >8 (P = 0.04). There were no differences in body composition as determined by dual-energy X-ray absorptiometry between groups in the three major body contents (i.e., bone, lean body mass, and fat) or in ovarian volume between groups. Conclusions: Matched for pubertal stage, PCOS daughters have similar levels of urinary androgens and gonadotropins as well as glucose-challenged salivary insulin levels.
Copyright © 2017 by the Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27778640      PMCID: PMC5413094          DOI: 10.1210/jc.2016-2707

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

1.  Editorial: The new instructions to authors for the reporting of steroid hormone measurements.

Authors:  Margaret E Wierman; Richard J Auchus; Daniel J Haisenleder; Janet E Hall; David Handelsman; Susan Hankinson; William Rosner; Ravinder J Singh; Patrick M Sluss; Frank Z Stanczyk
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

2.  Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.

Authors:  W K McGee; C V Bishop; A Bahar; C R Pohl; R J Chang; J C Marshall; F K Pau; R L Stouffer; J L Cameron
Journal:  Hum Reprod       Date:  2011-11-23       Impact factor: 6.918

3.  Earlier onset of puberty in girls: relation to increased body mass index and race.

Authors:  P B Kaplowitz; E J Slora; R C Wasserman; S E Pedlow; M E Herman-Giddens
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

4.  Urine excretion of androgen hormones in professional racing cyclists.

Authors:  M Maynar; M J Caballero; P Mena; C Rodríguez; R Cortés; J I Maynar
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

5.  Hirsutism: implications, etiology, and management.

Authors:  R Hatch; R L Rosenfield; M H Kim; D Tredway
Journal:  Am J Obstet Gynecol       Date:  1981-08-01       Impact factor: 8.661

6.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

Authors:  R S Legro; D Driscoll; J F Strauss; J Fox; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.

Authors:  Sarah C Kent; Carol L Gnatuk; Allen R Kunselman; Laurence M Demers; Peter A Lee; Richard S Legro
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

8.  Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women.

Authors:  A Dunaif; L Sorbara; R Delson; G Green
Journal:  Diabetes       Date:  1993-10       Impact factor: 9.461

9.  Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.

Authors:  Stephen Franks; Lisa J Webber; Micaela Goh; Anne Valentine; Davinia M White; Gerard S Conway; Steven Wiltshire; Mark I McCarthy
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

10.  Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.

Authors:  M Geoffrey Hayes; Margrit Urbanek; David A Ehrmann; Loren L Armstrong; Ji Young Lee; Ryan Sisk; Tugce Karaderi; Thomas M Barber; Mark I McCarthy; Stephen Franks; Cecilia M Lindgren; Corrine K Welt; Evanthia Diamanti-Kandarakis; Dimitrios Panidis; Mark O Goodarzi; Ricardo Azziz; Yi Zhang; Roland G James; Michael Olivier; Ahmed H Kissebah; Elisabet Stener-Victorin; Richard S Legro; Andrea Dunaif
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

View more
  14 in total

1.  Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome.

Authors:  Laura C Torchen; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Maternal polycystic ovarian syndrome and offspring growth: the Upstate KIDS Study.

Authors:  Griffith A Bell; Rajeshwari Sundaram; Sunni L Mumford; Hyojun Park; Miranda Broadney; James L Mills; Erin M Bell; Edwina H Yeung
Journal:  J Epidemiol Community Health       Date:  2018-05-22       Impact factor: 3.710

3.  Consequences of hyperandrogenemia during pregnancy in female offspring: attenuated response to angiotensin II.

Authors:  Noha M Shawky; Carolina Dalmasso; Norma B Ojeda; Yvonne Zuchowski; Nina Stachenfeld; Barbara T Alexander; Jane F Reckelhoff
Journal:  J Hypertens       Date:  2022-04-01       Impact factor: 4.844

4.  Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.

Authors:  Soren Harnois-Leblanc; Maria Isabel Hernandez; Ethel Codner; Fernando Cassorla; Sharon E Oberfield; Natasha I Leibel; Revi P Mathew; Svetlana Ten; Denis A Magoffin; Christianne J Lane; Michael I Goran; Ricardo Azziz; Jean-Patrice Baillargeon; David H Geller
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

Review 5.  Polycystic Ovary Syndrome: Insights from Preclinical Research.

Authors:  Jane F Reckelhoff; Noha M Shawky; Damian G Romero; Licy L Yanes Cardozo
Journal:  Kidney360       Date:  2022-06-17

Review 6.  Mechanisms of intergenerational transmission of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

Review 7.  Polycystic Ovary Syndrome: Ontogeny in Adolescence.

Authors:  Christine M Burt Solorzano; Christopher R McCartney
Journal:  Endocrinol Metab Clin North Am       Date:  2021-01-11       Impact factor: 4.741

8.  Cardiometabolic consequences of maternal hyperandrogenemia in male offspring.

Authors:  Yvonne Zuchowski; Carolina Dalmasso; Noha M Shawky; Jane F Reckelhoff
Journal:  Physiol Rep       Date:  2021-07

Review 9.  MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.

Authors:  Lina Schiffer; Punith Kempegowda; Wiebke Arlt; Michael W O'Reilly
Journal:  Eur J Endocrinol       Date:  2017-05-31       Impact factor: 6.664

10.  11-Oxygenated C19 Steroids Do Not Distinguish the Hyperandrogenic Phenotype of PCOS Daughters from Girls with Obesity.

Authors:  Laura C Torchen; Ryan Sisk; Richard S Legro; Adina F Turcu; Richard J Auchus; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.